Sulfamethoxazole And Trimethoprim Suspension
Product Images NDC 0121-0853

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulfamethoxazole And Trimethoprim (NDC 0121-0853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sulfamethoxazole 01)

Chemical structure of Sulfamethoxazole, an active ingredient in the Sulfamethoxazole and Trimethoprim suspension. The structure shows a benzene ring with an amino group (NH2) and a sulfonamide (SO2NH) attached, connected to an isoxazole ring containing nitrogen and oxygen atoms.*

FDA Label Image

Chemical Structure (Sulfamethoxazole 02)

Chemical structure diagram of sulfamethoxazole, an active ingredient in Sulfamethoxazole and Trimethoprim. The structure shows a sulfonamide group attached to a benzene ring with methoxy substituents and an amino-substituted pyrimidine ring.*

FDA Label Image

Principal Display Panel (20 mL Cup Label)

Label for Sulfamethoxazole and Trimethoprim Oral Suspension, USP, 800 mg/160 mg per 20 mL, 20 mL bottle. It includes instructions to shake well before using and notes the package is not child-resistant. Labeler identified as Pharmaceutical Associates, Inc., Greenville, SC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.